Jane Street Group, LLC Compugen LTD Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$4.09 - $7.16 $193,457 - $338,668	-47,300 Reduced 77.41%	13,800 $59,000
Q2 2021 Aug 16, 2021	BUY	$6.87 - $9.16 $342,813 - $457,084	49,900 Added 445.54%	61,100 $506,000
Q1 2021 May 18, 2021	SELL	$7.67 - $13.77 $99,710 - $179,010	-13,000 Reduced 53.72%	11,200 $96,000
Q3 2020 Nov 17, 2020	SELL	$14.16 - $19.45 $276,120 - $379,275	-19,500 Reduced 44.62%	24,200 $393,000
Q2 2020 Aug 17, 2020	BUY	$6.97 - $17.12 $304,589 - $748,144	43,700 New	43,700 $656,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.